{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T23:16:57Z","timestamp":1778887017638,"version":"3.51.4"},"reference-count":96,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T00:00:00Z","timestamp":1731628800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Breast Cancer Canada to liV Agency, Inc"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Oncology"],"abstract":"<jats:p>The accurate staging of breast cancer is fundamental for guiding treatment decisions and predicting patient outcomes. However, there can be considerable variation in routine clinical practice based on individual interpretation of guidelines and depending on the healthcare provider initially involved in working up patients newly diagnosed with breast cancer, ranging from primary care providers, triage nurses, surgeons, and\/or oncologists. The optimal approach for clinical staging, particularly in asymptomatic patients presenting with intermediate-risk disease, remains a topic of dialogue among clinicians. Given this area of uncertainty, the Research Excellence, Active Leadership (REAL) Canadian Breast Cancer Alliance conducted a modified Delphi process to assess the level of agreement among Canadian expert clinicians on various staging recommendations. In total, 20 items were drafted covering staging based on biological status, the utilization of localization clips, both for the axilla during diagnosis and primary surgical site for margins and radiation therapy planning, and the use of advanced imaging for the investigation of distant metastases. Overall, the consensus threshold among all participants (i.e., \u226575% agreement) was reached in 20\/20 items. Differences in clinical practice and recent findings from the literature are provided in the discussion. These consensus recommendations are meant to help standardize breast cancer staging practices in Canada, ensuring accurate diagnosis and optimal treatment planning.<\/jats:p>","DOI":"10.3390\/curroncol31110533","type":"journal-article","created":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T06:59:13Z","timestamp":1731653953000},"page":"7226-7243","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for Clinical Staging of Patients Newly Diagnosed with Breast Cancer"],"prefix":"10.3390","volume":"31","author":[{"given":"Jeffrey Q.","family":"Cao","sequence":"first","affiliation":[{"name":"Arthur Child Comprehensive Cancer Centre, Calgary, AB T2N 5G2, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brae","family":"Surgeoner","sequence":"additional","affiliation":[{"name":"Alberta Health Service, Calgary, AB T2S 3C3, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4344-7913","authenticated-orcid":false,"given":"Mita","family":"Manna","sequence":"additional","affiliation":[{"name":"Saskatoon Cancer Centre, Saskatoon, SK S7N 4H4, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Fran\u00e7ois","family":"Boileau","sequence":"additional","affiliation":[{"name":"Jewish General Hospital, Montreal, QC H3T 1E2, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4111-2757","authenticated-orcid":false,"given":"Karen A.","family":"Gelmon","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, University of British Columbia, Vancouver, BC V5Z 1M9, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7741-2199","authenticated-orcid":false,"given":"Muriel","family":"Brackstone","sequence":"additional","affiliation":[{"name":"London Health Sciences Centre, London, ON N6A 5W9, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4818-318X","authenticated-orcid":false,"given":"Christine","family":"Brezden-Masley","sequence":"additional","affiliation":[{"name":"Mount Sinai Hospital, Toronto, ON M5G 1X5, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarzyna J.","family":"Jerzak","sequence":"additional","affiliation":[{"name":"Sunnybrook Health Sciences, Toronto, ON M4N 3M5, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0730-5363","authenticated-orcid":false,"given":"Ipshita","family":"Prakash","sequence":"additional","affiliation":[{"name":"Jewish General Hospital, Montreal, QC H3T 1E2, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandeep","family":"Sehdev","sequence":"additional","affiliation":[{"name":"The Ottawa Hospital Cancer Centre, Ottawa, ON K1H 8L6, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie M.","family":"Wong","sequence":"additional","affiliation":[{"name":"McGill University Health Centre, Montreal, QC H4A 3J1, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathaniel","family":"Bouganim","sequence":"additional","affiliation":[{"name":"McGill University Health Centre, Montreal, QC H4A 3J1, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1080-0998","authenticated-orcid":false,"given":"David W.","family":"Cescon","sequence":"additional","affiliation":[{"name":"Princess Margaret Cancer Centre, Toronto, ON M5G 2M9, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Chia","sequence":"additional","affiliation":[{"name":"BC Cancer\u2014Vancouver, Vancouver, BC V5Z 4E6, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian S.","family":"Dayes","sequence":"additional","affiliation":[{"name":"Juravinski Cancer Center, McMaster University, Hamilton, ON L8V 5C2, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anil Abraham","family":"Joy","sequence":"additional","affiliation":[{"name":"Cross Cancer Institute, Edmonton, AB T6G 1Z2, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5768-6379","authenticated-orcid":false,"given":"Jan-Willem","family":"Henning","sequence":"additional","affiliation":[{"name":"Arthur Child Comprehensive Cancer Centre, Calgary, AB T2N 5G2, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,11,15]]},"reference":[{"key":"ref_1","unstructured":"(2024, October 16). Breast Cancer Canada. Available online: https:\/\/breastcancerprogress.ca\/."},{"key":"ref_2","unstructured":"(2024, October 16). REAL Alliance\u2014Canadian Breast Cancer Alliance. Available online: https:\/\/realalliance.ca\/."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.3390\/curroncol28030203","article-title":"Staging Investigations in Asymptomatic Early Breast Cancer Patients at the Cancer Centre of Southeastern Ontario","volume":"28","author":"Kamel","year":"2021","journal-title":"Curr. Oncol."},{"key":"ref_4","unstructured":"Chaudhry, M. (2024, October 16). Cancer System Quality Index 2021\u2014Ontario. Available online: https:\/\/www.ontariohealth.ca\/sites\/ontariohealth\/files\/csqi-report-2021.pdf."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1002\/jhm.2425","article-title":"Choosing Wisely\u00ae: Things We Do for No Reason","volume":"10","author":"Feldman","year":"2015","journal-title":"J. Hosp. Med."},{"key":"ref_6","first-page":"829","article-title":"Assessment of the Strength of Recommendation and Quality of Evidence: GRADE Checklist. A Descriptive Study","volume":"140","author":"Bezerra","year":"2022","journal-title":"S\u00e3o Paulo Med. J."},{"key":"ref_7","unstructured":"Gradishar, W. (2024, October 30). NCCN Guidelines\u00ae Insights: Breast Cancer, Version 5.2024. Available online: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/breast.pdf."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.annonc.2023.11.016","article-title":"Early Breast Cancer: ESMO Clinical Practice Guideline for Diagnosis, Treatment and Follow-Up","volume":"35","author":"Loibl","year":"2024","journal-title":"Ann. Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e123","DOI":"10.3747\/co.27.6147","article-title":"Baseline Staging Imaging for Distant Metastasis in Women with Stages I, II, and III Breast Cancer","volume":"27","author":"Arnaout","year":"2020","journal-title":"Curr. Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"E100","DOI":"10.1503\/cjs.003519","article-title":"Unwarranted Imaging for Distant Metastases in Patients with Newly Diagnosed Ductal Carcinoma in Situ and Stage I and II Breast Cancer","volume":"63","author":"Lupichuk","year":"2020","journal-title":"Can. J. Surg."},{"key":"ref_11","unstructured":"B\u00e9land, M., Boily, G., Dufour, V., Gosselin, C., Lanthier, J., Paquin, M.-C., Provost, V., and Roy, M.-C. (2024, August 16). INESSS\u2014Algorithmes D\u2019investigation, de Traitement et de Suivi Pour le Cancer. Available online: https:\/\/inesss.algorithmes-onco.info."},{"key":"ref_12","unstructured":"(2024, August 16). BC Cancer\u2014Staging. Available online: http:\/\/www.bccancer.bc.ca\/books\/breast\/staging."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"5539","DOI":"10.7314\/APJCP.2014.15.14.5539","article-title":"Breast Cancer Recurrence According to Molecular Subtype","volume":"15","author":"Shim","year":"2014","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1200\/JCO.2009.24.9284","article-title":"Breast Cancer Subtypes and the Risk of Local and Regional Relapse","volume":"28","author":"Voduc","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/ijc.31914","article-title":"Ten-Year Recurrence Rates for Breast Cancer Subtypes in the Netherlands: A Large Population-Based Study","volume":"144","author":"Strobbe","year":"2019","journal-title":"Int. J. Cancer"},{"key":"ref_16","first-page":"772","article-title":"Use of Contrast-Enhanced Computed Tomography in Clinical Staging of Asymptomatic Breast Cancer Patients to Detect Asymptomatic Distant Metastases","volume":"3","author":"Tanaka","year":"2012","journal-title":"Oncol. Lett."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S1076-6332(97)80154-7","article-title":"Detection of Breast Cancer at a Smaller Size Can Reduce the Likelihood of Metastatic Spread: A Quantitative Analysis","volume":"4","author":"Sivaramakrishna","year":"1997","journal-title":"Acad. Radiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1111\/j.1445-2197.2006.03918.x","article-title":"Tumour Size as a Predictor of Axillary Node Metastases in Patients with Breast Cancer","volume":"76","author":"Laura","year":"2006","journal-title":"ANZ J. Surg."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s10549-018-4796-9","article-title":"The Relationship between Tumour Size, Nodal Status and Distant Metastases: On the Origins of Breast Cancer","volume":"170","author":"Sopik","year":"2018","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1200\/GO.20.00257","article-title":"Clinicopathologic Features Predictive of Distant Metastasis in Patients Diagnosed With Invasive Breast Cancer","volume":"6","author":"Ali","year":"2020","journal-title":"JCO Glob. Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1159\/000516114","article-title":"St. Gallen\/Vienna 2021: A Brief Summary of the Consensus Discussion on Customizing Therapies for Women with Early Breast Cancer","volume":"16","author":"Thomssen","year":"2021","journal-title":"Breast Care"},{"key":"ref_22","first-page":"311","article-title":"Staging of the Axilla in Breast Cancer and the Evolving Role of Axillary Ultrasound","volume":"13","author":"Chen","year":"2021","journal-title":"Breast Cancer (Dove Med. Press)"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ejso.2009.09.007","article-title":"Breast MRI in Clinically and Mammographically Occult Breast Cancer Presenting with an Axillary Metastasis: A Systematic Review","volume":"36","year":"2010","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jamcollsurg.2007.07.046","article-title":"MRI Identifies Otherwise Occult Disease in Select Patients with Paget Disease of the Nipple","volume":"206","author":"Morrogh","year":"2008","journal-title":"J. Am. Coll. Surg."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/01.rli.0000163742.40401.4e","article-title":"Paget Disease of the Breast: Findings at Magnetic Resonance Imaging and Histopathologic Correlation","volume":"40","author":"Frei","year":"2005","journal-title":"Investig. Radiol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1200\/JCO.2009.23.0839","article-title":"Prospective Multicenter Cohort Study to Refine Management Recommendations for Women at Elevated Familial Risk of Breast Cancer: The EVA Trial","volume":"28","author":"Kuhl","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"ref_27","unstructured":"Muradali, D., Fletcher, G.G., Cordeiro, E., Fienberg, S., George, R., Kulkarni, S., Seely, J., Shaheen, R., Eisen, A., and The Preoperative Breast MRI Expert Panel (2024, August 16). CCO. Preoperative Breast Magnetic Resonance Imaging Guideline. Available online: https:\/\/www.cancercareontario.ca\/en\/guidelines-advice\/types-of-cancer\/70786."},{"key":"ref_28","first-page":"159","article-title":"The Application of Breast MRI in Staging and Screening for Breast Cancer","volume":"19","author":"Gundry","year":"2005","journal-title":"Oncology"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1200\/JCO.2007.15.2108","article-title":"Accuracy and Surgical Impact of Magnetic Resonance Imaging in Breast Cancer Staging: Systematic Review and Meta-Analysis in Detection of Multifocal and Multicentric Cancer","volume":"26","author":"Houssami","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1001\/archsurg.2012.1660","article-title":"Selective Preoperative Magnetic Resonance Imaging in Women with Breast Cancer: No Reduction in the Reoperation Rate","volume":"147","author":"Weber","year":"2012","journal-title":"Arch. Surg."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.jamcollsurg.2013.01.011","article-title":"Factors Associated with the Frequency of Initial Total Mastectomy: Results of a Multi-Institutional Study","volume":"216","author":"Feigelson","year":"2013","journal-title":"J. Am. Coll. Surg."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1245\/s10434-011-1932-8","article-title":"The Influence of Preoperative MRI on Breast Cancer Treatment","volume":"19","author":"Miller","year":"2012","journal-title":"Ann. Surg. Oncol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.1200\/JCO.21.00934","article-title":"Management of the Axilla in Early-Stage Breast Cancer: Ontario Health (Cancer Care Ontario) and ASCO Guideline","volume":"39","author":"Brackstone","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1056\/NEJMoa1612645","article-title":"Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy","volume":"376","author":"Masuda","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1056\/NEJMoa2105215","article-title":"Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer","volume":"384","author":"Tutt","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1056\/NEJMoa1814017","article-title":"Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer","volume":"380","author":"Huang","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"GS02","DOI":"10.1158\/1538-7445.SABCS23-GS02-07","article-title":"Abstract GS02-07: Loco-Regional Irradiation in Patients with Biopsy-Proven Axillary Node Involvement at Presentation Who Become Pathologically Node-Negative After Neoadjuvant Chemotherapy: Primary Outcomes of NRG Oncology\/NSABP B-51\/RTOG 1304","volume":"84","author":"Mamounas","year":"2024","journal-title":"Cancer Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1002\/cncr.25152","article-title":"Cytologically Proven Axillary Lymph Node Metastases Are Eradicated in Patients Receiving Preoperative Chemotherapy with Concurrent Trastuzumab for HER2-Positive Breast Cancer","volume":"116","author":"Dominici","year":"2010","journal-title":"Cancer"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1001\/jama.2013.278932","article-title":"Sentinel Lymph Node Surgery after Neoadjuvant Chemotherapy in Patients with Node-Positive Breast Cancer: The ACOSOG Z1071 (Alliance) Clinical Trial","volume":"310","author":"Boughey","year":"2013","journal-title":"JAMA"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"4337","DOI":"10.1245\/s10434-019-07809-7","article-title":"Axillary Lymph Node Ultrasound Following Neoadjuvant Chemotherapy in Biopsy-Proven Node-Positive Breast Cancer: Results from the SN FNAC Study","volume":"26","author":"Morency","year":"2019","journal-title":"Ann. Surg. Oncol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1470-2045(13)70166-9","article-title":"Sentinel-Lymph-Node Biopsy in Patients with Breast Cancer before and after Neoadjuvant Chemotherapy (SENTINA): A Prospective, Multicentre Cohort Study","volume":"14","author":"Kuehn","year":"2013","journal-title":"Lancet Oncol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s10549-018-5004-7","article-title":"Sentinel Lymph Node Biopsy without Axillary Lymphadenectomy after Neoadjuvant Chemotherapy Is Accurate and Safe for Selected Patients: The GANEA 2 Study","volume":"173","author":"Classe","year":"2019","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1200\/JCO.2015.64.0094","article-title":"Improved Axillary Evaluation Following Neoadjuvant Therapy for Patients With Node-Positive Breast Cancer Using Selective Evaluation of Clipped Nodes: Implementation of Targeted Axillary Dissection","volume":"34","author":"Caudle","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1001\/jamasurg.2022.3907","article-title":"Diagnostic Accuracy of Radioactive Iodine Seed Placement in the Axilla With Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Node-Positive Breast Cancer","volume":"157","author":"Simons","year":"2022","journal-title":"JAMA Surg."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/SLA.0000000000003075","article-title":"Diagnostic Accuracy of Different Surgical Procedures for Axillary Staging After Neoadjuvant Systemic Therapy in Node-Positive Breast Cancer: A Systematic Review and Meta-Analysis","volume":"269","author":"Simons","year":"2019","journal-title":"Ann. Surg."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1097\/00007611-198809000-00011","article-title":"Breast Cancer: Metastatic Patterns and Their Prognosis","volume":"81","author":"Patanaphan","year":"1988","journal-title":"South. Med. J."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12957-019-1584-x","article-title":"A Critical Review of the Chest CT Scans Performed to Detect Asymptomatic Synchronous Metastasis in New and Recurrent Breast Cancers","volume":"17","author":"James","year":"2019","journal-title":"World J. Surg. Oncol."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Bruckmann, N.M., Kirchner, J., Morawitz, J., Umutlu, L., Herrmann, K., Bittner, A.-K., Hoffmann, O., Mohrmann, S., Ingenwerth, M., and Schaarschmidt, B.M. (2021). Prospective Comparison of CT and 18F-FDG PET\/MRI in N and M Staging of Primary Breast Cancer Patients: Initial Results. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0260804"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"8714","DOI":"10.1007\/s00330-021-07956-0","article-title":"Prospective Comparison of the Diagnostic Accuracy of 18F-FDG PET\/MRI, MRI, CT, and Bone Scintigraphy for the Detection of Bone Metastases in the Initial Staging of Primary Breast Cancer Patients","volume":"31","author":"Bruckmann","year":"2021","journal-title":"Eur. Radiol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1007\/s00259-024-06696-9","article-title":"Joint EANM-SNMMI Guideline on the Role of 2-[18F]FDG PET\/CT in No Special Type Breast Cancer","volume":"51","author":"Vaz","year":"2024","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.suronc.2013.03.001","article-title":"18FDG PET-CT for Diagnosis of Distant Metastases in Breast Cancer Patients. A Meta-Analysis","volume":"22","author":"Hong","year":"2013","journal-title":"Surg. Oncol."},{"key":"ref_52","first-page":"672","article-title":"Comparison of Whole-Body PET\/PET-CT and Conventional Imaging Procedures for Distant Metastasis Staging in Patients with Breast Cancer: A Meta-Analysis","volume":"36","author":"Sun","year":"2015","journal-title":"Eur. J. Gynaecol. Oncol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s12282-014-0542-2","article-title":"Clinical Significance of FDG-PET\/CT at the Postoperative Surveillance in the Breast Cancer Patients","volume":"23","author":"Jung","year":"2016","journal-title":"Breast Cancer"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.cpet.2009.09.002","article-title":"False-Negative and False-Positive Results in FDG-PET and PET\/CT in Breast Cancer","volume":"4","author":"Kumar","year":"2009","journal-title":"PET Clin."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1053\/j.semnuclmed.2021.04.005","article-title":"PET\/CT Variants and Pitfalls in Breast Cancers","volume":"51","author":"Kikano","year":"2021","journal-title":"Semin. Nucl. Med."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1200\/JCO.2011.38.1103","article-title":"Prospective Study of 2-[18F]Fluorodeoxyglucose Positron Emission Tomography in the Assessment of Regional Nodal Spread of Disease in Patients with Breast Cancer: An Ontario Clinical Oncology Group Study","volume":"30","author":"Pritchard","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"252","DOI":"10.2967\/jnumed.116.178749","article-title":"Rate of Distant Metastases on 18F-FDG PET\/CT at Initial Staging of Breast Cancer: Comparison of Women Younger and Older Than 40 Years","volume":"58","author":"Lebon","year":"2017","journal-title":"J. Nucl. Med."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.1245\/s10434-019-07543-0","article-title":"Overuse of Preoperative Staging of Patients Undergoing Neoadjuvant Chemotherapy for Breast Cancer","volume":"26","author":"Srour","year":"2019","journal-title":"Ann. Surg. Oncol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1093\/jnci\/djs451","article-title":"Prognostic Impact of (18)FDG-PET-CT Findings in Clinical Stage III and IIB Breast Cancer","volume":"104","author":"Groheux","year":"2012","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1200\/JCO.23.00249","article-title":"Impact of 18F-Labeled Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography Versus Conventional Staging in Patients With Locally Advanced Breast Cancer","volume":"41","author":"Dayes","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.6004\/jnccn.2020.7598","article-title":"Use of 18F-FDG PET\/CT as an Initial Staging Procedure for Stage II-III Breast Cancer: A Multicenter Value Analysis","volume":"18","author":"Hyland","year":"2020","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s40336-021-00426-z","article-title":"Breast Cancer: Initial Workup and Staging with FDG PET\/CT","volume":"9","author":"Groheux","year":"2021","journal-title":"Clin. Transl. Imaging"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Ming, Y., Wu, N., Qian, T., Li, X., Wan, D.Q., Li, C., Li, Y., Wu, Z., Wang, X., and Liu, J. (2020). Progress and Future Trends in PET\/CT and PET\/MRI Molecular Imaging Approaches for Breast Cancer. Front. Oncol., 10.","DOI":"10.3389\/fonc.2020.01301"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.2967\/jnumed.111.093864","article-title":"The Yield of 18F-FDG PET\/CT in Patients with Clinical Stage IIA, IIB, or IIIA Breast Cancer: A Prospective Study","volume":"52","author":"Groheux","year":"2011","journal-title":"J. Nucl. Med."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"4711","DOI":"10.1245\/s10434-020-08895-8","article-title":"Population Trends in Lobular Carcinoma of the Breast: The Ontario Experience","volume":"27","author":"Lima","year":"2020","journal-title":"Ann. Surg. Oncol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.2967\/jnumed.115.161455","article-title":"Comparison of 18F-FDG PET\/CT for Systemic Staging of Newly Diagnosed Invasive Lobular Carcinoma Versus Invasive Ductal Carcinoma","volume":"56","author":"Hogan","year":"2015","journal-title":"J. Nucl. Med."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3109\/0284186X.2015.1054952","article-title":"Is (18)F-FDG PET\/CT an Accurate Tool for Identifying Metastases of Lobular Breast Cancer?","volume":"55","author":"Orevi","year":"2016","journal-title":"Acta Oncol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"326","DOI":"10.2967\/jnumed.120.247882","article-title":"Head-to-Head Evaluation of 18F-FES and 18F-FDG PET\/CT in Metastatic Invasive Lobular Breast Cancer","volume":"62","author":"Ulaner","year":"2021","journal-title":"J. Nucl. Med."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.critrevonc.2014.09.003","article-title":"Inflammatory Breast Cancer: An Overview","volume":"93","author":"Westenberg","year":"2015","journal-title":"Crit. Rev. Oncol.\/Hematol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s10549-015-3436-x","article-title":"Overall Survival Differences between Patients with Inflammatory and Noninflammatory Breast Cancer Presenting with Distant Metastasis at Diagnosis","volume":"152","author":"Fouad","year":"2015","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1093\/annonc\/mdu121","article-title":"Survival of Women with Inflammatory Breast Cancer: A Large Population-Based Study","volume":"25","author":"Dawood","year":"2014","journal-title":"Ann. Oncol. Off. J. Eur. Soc. Med. Oncol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.acra.2012.01.001","article-title":"Semiquantitative Analysis of Maximum Standardized Uptake Values of Regional Lymph Nodes in Inflammatory Breast Cancer: Is There a Reliable Threshold for Differentiating Benign from Malignant?","volume":"19","author":"Carkaci","year":"2012","journal-title":"Acad. Radiol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s10549-007-9671-z","article-title":"Inflammatory Breast Cancer: PET\/CT, MRI, Mammography, and Sonography Findings","volume":"109","author":"Yang","year":"2008","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"5038","DOI":"10.1002\/cncr.24534","article-title":"18F-Fluorodeoxyglucose Positron Emission Tomography\/Computed Tomography (FDG-PET\/CT) Imaging in the Staging and Prognosis of Inflammatory Breast Cancer","volume":"115","author":"Alberini","year":"2009","journal-title":"Cancer"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"231","DOI":"10.2967\/jnumed.108.056010","article-title":"Retrospective Study of 18F-FDG PET\/CT in the Diagnosis of Inflammatory Breast Cancer: Preliminary Data","volume":"50","author":"Carkaci","year":"2009","journal-title":"J. Nucl. Med."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2967\/jnumed.112.106864","article-title":"18F-FDG PET\/CT in Staging Patients with Locally Advanced or Inflammatory Breast Cancer: Comparison to Conventional Staging","volume":"54","author":"Groheux","year":"2013","journal-title":"J. Nucl. Med."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1634\/theoncologist.2011-0089","article-title":"FDG-PET\/CT Compared with Conventional Imaging in the Detection of Distant Metastases of Primary Breast Cancer","volume":"16","author":"Niikura","year":"2011","journal-title":"Oncologist"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/j.ijrobp.2011.10.040","article-title":"Pretreatment Staging Positron Emission Tomography\/Computed Tomography in Patients with Inflammatory Breast Cancer Influences Radiation Treatment Field Designs","volume":"83","author":"Walker","year":"2012","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1007\/s00259-013-2405-z","article-title":"18F-FDG PET\/CT Imaging versus Dynamic Contrast-Enhanced CT for Staging and Prognosis of Inflammatory Breast Cancer","volume":"40","author":"Champion","year":"2013","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s10549-020-05929-3","article-title":"FDG-PET\/CT in High-Risk Primary Breast Cancer-a Prospective Study of Stage Migration and Clinical Impact","volume":"185","author":"Vogsen","year":"2021","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s10549-013-2678-8","article-title":"Pre-Chemotherapy 18F-FDG PET\/CT Upstages Nodal Stage in Stage II-III Breast Cancer Patients Treated with Neoadjuvant Chemotherapy","volume":"141","author":"Koolen","year":"2013","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1093\/neuonc\/noaa285","article-title":"The Incidence of Brain Metastases among Patients with Metastatic Breast Cancer: A Systematic Review and Meta-Analysis","volume":"23","author":"Kuksis","year":"2020","journal-title":"Neuro-Oncology"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2147\/CMAR.S72592","article-title":"Management of Patients with Hormone Receptor\u2013Positive Breast Cancer with Visceral Disease: Challenges and Treatment Options","volume":"7","author":"Harb","year":"2015","journal-title":"Cancer Manag. Res."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1200\/JCO.2001.19.13.3297","article-title":"Meningeal Carcinomatosis from Breast Carcinoma Responsive to Trastuzumab","volume":"19","author":"Baculi","year":"2001","journal-title":"J. Clin. Oncol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S1470-2045(24)00004-4","article-title":"Activity and Safety of Enobosarm, a Novel, Oral, Selective Androgen Receptor Modulator, in Androgen Receptor-Positive, Oestrogen Receptor-Positive, and HER2-Negative Advanced Breast Cancer (Study G200802): A Randomised, Open-Label, Multicentre, Multinational, Parallel Design, Phase 2 Trial","volume":"25","author":"Palmieri","year":"2024","journal-title":"Lancet Oncol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"e54","DOI":"10.1016\/j.clbc.2019.06.007","article-title":"Incidence of Brain Metastases in Nonmetastatic and Metastatic Breast Cancer: Is There a Role for Screening?","volume":"20","author":"Komorowski","year":"2020","journal-title":"Clin. Breast Cancer"},{"key":"ref_87","first-page":"1","article-title":"Canada: Health System Review","volume":"22","author":"Marchildon","year":"2020","journal-title":"Health Syst. Transit."},{"key":"ref_88","unstructured":"Barua, B., Rovere, M.C., and Skinner, B.J. (2024, August 16). Waiting Your Turn: Wait Times for Health Care in Canada 2010 Report. Studies in Health Care Policy. Available online: https:\/\/ssrn.com\/abstract=1783079."},{"key":"ref_89","unstructured":"Anderson, B. (2024, August 16). The Resumption of Radiology Clinical Services in Canada\u2014Canadian Association of Radiologists. Available online: https:\/\/car.ca\/wp-content\/uploads\/2020\/05\/CAR-Radiology-Resumption-of-Clinical-Services-Report_FINAL.pdf."},{"key":"ref_90","first-page":"e1919","article-title":"Reduced Time to Breast Cancer Diagnosis with Coordination of Radiological and Clinical Care","volume":"9","author":"McKevitt","year":"2017","journal-title":"Cureus"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"e377","DOI":"10.3747\/co.27.6115","article-title":"Breast Cancer Diagnosis and Treatment Wait Times in Specialized Diagnostic Units Compared with Usual Care: A Population-Based Study","volume":"27","author":"Webber","year":"2020","journal-title":"Curr. Oncol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"595","DOI":"10.17269\/s41997-019-00210-7","article-title":"Comparison of Wait Times across the Breast Cancer Treatment Pathway among Screened Women Undergoing Organized Breast Assessment versus Usual Care","volume":"110","author":"Blackmore","year":"2019","journal-title":"Can. J. Public Health"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"358","DOI":"10.24095\/hpcdp.38.10.02","article-title":"Breast Cancer Detection Method, Diagnostic Interval and Use of Specialized Diagnostic Assessment Units across Ontario, Canada","volume":"38","author":"Jiang","year":"2018","journal-title":"Health Promot. Chronic Dis. Prev. Can."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.3390\/curroncol30010095","article-title":"Assurance of Timely Access to Breast Cancer Diagnosis and Treatment by a Regional Breast Health Clinic Serving Both Urban and Rural-Remote Communities","volume":"30","author":"Ewart","year":"2023","journal-title":"Curr. Oncol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"e220143","DOI":"10.1148\/rg.220143","article-title":"18F-Fluoroestradiol: Current Applications and Future Directions","volume":"43","author":"Edmonds","year":"2023","journal-title":"RadioGraphics"},{"key":"ref_96","first-page":"e44061","article-title":"Novel Technologies in Breast Imaging: A Scoping Review","volume":"15","author":"Grigoryants","year":"2023","journal-title":"Cureus"}],"container-title":["Current Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1718-7729\/31\/11\/533\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:33:08Z","timestamp":1760113988000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1718-7729\/31\/11\/533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,15]]},"references-count":96,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,11]]}},"alternative-id":["curroncol31110533"],"URL":"https:\/\/doi.org\/10.3390\/curroncol31110533","relation":{},"ISSN":["1718-7729"],"issn-type":[{"value":"1718-7729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,15]]}}}